RxDoctor Payments Data

Jack Diep, MD

Interventional Pain Medicine · Lake Havasu City, AZNPI 1912333014

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 76.5% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2021 at $67,433 and has fallen 80.7% since, to $13,039 in 2025. Among interventional pain medicine clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$232,637in general payments, 2019–2025

Across 957 payments — averaging $243.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$178K
  • Aurora Spine, Inc.$27K
  • Medtronic$8K
  • Abbott$6K
  • Saluda Medical Americas, Inc.$4K
  • Vertos Medical, Inc.$2K
  • plus $8K from 27 others
$1,246in research payments, 2019–2025

Across 3 payments — averaging $415.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Nalu Medical, Inc.$1K
  • Saluda Medical Americas, Inc.$196

What the payments were for

  • Royalty or licence$5,0302%
  • Consulting fees$49,35021%
  • Speaking & faculty fees$119,78851%
  • Travel & lodging$16,6217%
  • Food & beverage$41,74818%
  • Education$1010%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$232,637 in reported general payments places this provider in the 95th percentile of 64 interventional pain medicine providers in Arizona.

See all interventional pain medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$644,948
Medicare patients
679
Services billed
10,856

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen686$13,661
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen225$7,803
Xtampza ErOxycodone Myristate14$6,577
Naloxone Hcl77$5,088
Pregabalin76$3,366
Gabapentin261$3,320
Diclofenac Sodium52$3,138
Tramadol Hcl368$2,004
Oxycodone Hcl137$2,003
Lidocaine21$1,767
Tizanidine Hcl103$951
Methocarbamol75$921
Duloxetine Hcl16$783
Morphine Sulfate ErMorphine Sulfate30$675
Cyclobenzaprine Hcl101$642

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Lake Havasu City

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →